Medindia LOGIN REGISTER
Medindia
Advertisement

Fibroblast Growth Factor 18 Identified as an Ovarian Cancer Biomarker

by Rukmani Krishna on September 12, 2013 at 12:18 AM
 Fibroblast Growth Factor 18 Identified as an Ovarian Cancer Biomarker

Ovarian cancer is one of the leading causes of cancer-related death in women and is often not detected until the later stages of disease, which contributes to poor prognosis. Biomarkers that can be used for early diagnosis and outcome have been identified; however, many of these have not been evaluated at the biological and clinical levels.

In this issue of the Journal of Clinical Investigation, Michael Birrer and colleagues at Massachusetts General Hospital identify fibroblast growth factor 18 (FGF18) as a predictive marker for poor overall survival in ovarian cancer patients. Overexpression of the gene encoding FGF18 was associated with enhanced tumor blood vessel formation and expression of cancer promoting cytokines. These data indicate that further studies on the predictive potential FGF18 and its use as a therapeutic target in ovarian cancer are warranted.

Advertisement

Source: Eurekalert

Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Cancer News

Blood Test for Early Detection of Pancreatic Cancer
The blood test pinpointed 13 proteins capable of distinguishing between early and late stages of pancreatic cancer.
Nutrients in Beef and Dairy Promote Cancer Immunotherapy
A fatty acid present in dairy products, beef, and lamb called trans-vaccenic acid enhances immune cells' capacity to combat cancers.
Combination Therapy Holds Promise for Brain Tumor in Children
Trametinib plus dabrafenib combined therapy demonstrated a clear therapeutic benefit in children with BRAF-mutated low- and high-grade gliomas.
Urban Environments Fuel Higher Breast Cancer Rates
Examining breast cancer occurrence and stages reveals disparities in urban versus rural rates, influenced by environmental conditions and the stage of the disease.
DNA Repair Pathway Linked to Breast, Ovarian, and Prostate Cancers
Polymerases theta and delta assist in the development of new cancer drugs known as polymerase theta inhibitors, currently undergoing clinical trials.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Fibroblast Growth Factor 18 Identified as an Ovarian Cancer Biomarker Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests